A Study of ABT-450 With
Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Verified by: Abbott, August 2012
First Received: September 28, 2011 | Last Updated: August 12, 2012
Phase: Phase 2 | Start Date: October 2011
Overall Status: Active, not recruiting | Estimated Enrollment: 560
Official Title: “A Randomized, Open Label, Multi-center Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 With Ritonavir (ABT-450/r)